Study of outgoing longwave radiation anomalies associated with Haiti earthquake

The paper presents an analysis by using the methods of Eddy field calculation mean and wavelet maxima to detect seismic anomalies within the outgoing longwave radiation (OLR) data based on time and space. The distinguishing feature of the method of Eddy field calculation mean is that we can calculate "the total sum of the difference value" of "the measured value" between adjacent points, which could highlight the singularity within data. The identified singularities are further validated by wavelet maxima, which using wavelet transformations as data mining tools by computing the maxima that can be used to identify obvious anomalies within OLR data. The two methods has been applied to carry out a comparative analysis of OLR data associated with the earthquake recently occurred in Haiti on 12 January 2010. Combining with the tectonic explanation of spatial and temporal continuity of the abnormal phenomena, the analyzed results have indicated a number of singularities associated with the possible seismic anomalies of the earthquake and from the comparative experiments and analyses by using the two methods, which follow the same time and space, we conclude that the singularities observed from 19 to 24 December 2009 could be the earthquake precursor of Haiti earthquake

Dilepton Production at SPS-energy Heavy Ion Collisions

The production of dileptons is studied within a hadronic transport model. We investigate the sensitivity of the dilepton spectra to the initial configuration of the hadronic phase in a ultrarelativistic heavy ion collision. Possible in medium correction due to the modifications of pions and the pion form factor in a hadronic gas are discussed.Comment: Dedicated to Gerry Brown in honor of the 32nd celebration of his 39th birthday. 31 pages Latex including 13 eps-figures, uses psfig.sty and epsf.st

A Green's function approach to transmission of massless Dirac fermions in graphene through an array of random scatterers

We consider the transmission of massless Dirac fermions through an array of short range scatterers which are modeled as randomly positioned $\delta$- function like potentials along the x-axis. We particularly discuss the interplay between disorder-induced localization that is the hallmark of a non-relativistic system and two important properties of such massless Dirac fermions, namely, complete transmission at normal incidence and periodic dependence of transmission coefficient on the strength of the barrier that leads to a periodic resonant transmission. This leads to two different types of conductance behavior as a function of the system size at the resonant and the off-resonance strengths of the delta function potential. We explain this behavior of the conductance in terms of the transmission through a pair of such barriers using a Green's function based approach. The method helps to understand such disordered transport in terms of well known optical phenomena such as Fabry Perot resonances.Comment: 22 double spaced single column pages. 15 .eps figure

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease

The relationship between body-mass index (BMI) and Alzheimer´s disease (AD) has been extensively investigated. However, BMI alterations in preclinical individuals with autosomal dominant AD (ADAD) have not yet been investigated. We analyzed cross-sectional data from 230 asymptomatic members of families with ADAD participating in the Dominantly Inherited Alzheimer Network (DIAN) study including 120 preclinical mutation carriers (MCs) and 110 asymptomatic non-carriers (NCs). Differences in BMI and their relation with cerebral amyloid load and episodic memory as a function of estimated years to symptom onset (EYO) were analyzed. Preclinical MCs showed significantly lower BMIs compared to NCs, starting 11.2 years before expected symptom onset. However, the BMI curves begun to diverge already at 17.8 years before expected symptom onset. Lower BMI in preclinical MCs was significantly associated with less years before estimated symptom onset, higher global Aβ brain burden, and with lower delayed total recall scores in the logical memory test. The study provides cross-sectional evidence that weight loss starts one to two decades before expected symptom onset of ADAD. Our findings point toward a link between the pathophysiology of ADAD and disturbance of weight control mechanisms. Longitudinal follow-up studies are warranted to investigate BMI changes over time

Testing Oscillating Primordial Spectrum and Oscillating Dark Energy with Astronomical Observations

In this paper we revisit the issue of determining the oscillating primordial scalar power spectrum and oscillating equation of state of dark energy from the astronomical observations. By performing a global analysis with the Markov Chain Monte Carlo method, we find that the current observations from five-year WMAP and SDSS-LRG matter power spectrum, as well as the "union" supernovae sample, constrain the oscillating index of primordial spectrum and oscillating equation of state of dark energy with the amplitude less than $|n_{\rm amp}|<0.116$ and $|w_{\rm amp}|<0.232$ at 95% confidence level, respectively. This result shows that the oscillatory structures on the primordial scalar spectrum and the equation of state of dark energy are still allowed by the current data. Furthermore, we point out that these kinds of modulation effects will be detectable (or gotten a stronger constraint) in the near future astronomical observations, such as the PLANCK satellite, LAMOST telescope and the currently ongoing supernovae projects SNLS.Comment: 7 pages, 5 figures, 1 tabe

High brightness formamidinium lead bromide perovskite nanocrystal light emitting devices

Formamidinium lead halide (FAPbX3) has attracted greater attention and is more prominent recently in photovoltaic devices due to its broad absorption and higher thermal stability in comparison to more popular methylammonium lead halide MAPbX3. Herein, a simple and highly reproducible room temperature synthesis of device grade high quality formamidinium lead bromide CH(NH2)2 PbBr3 (FAPbBr3) colloidal nanocrystals (NC) having high photoluminescence quantum efficiency (PLQE) of 55-65% is reported. In addition, we demonstrate high brightness perovskite light emitting device (Pe-LED) with these FAPbBr3 perovskite NC thin film using 2,2′,2″-(1,3,5-Benzinetriyl)-tris(1-phenyl-1-H-benzimidazole) commonly known as TPBi and 4,6-Bis(3,5-di(pyridin-3-yl)phenyl)-2-methylpyrimidine (B3PYMPM) as electron transport layers (ETL). The Pe-LED device with B3PYMPM as ETL has bright electroluminescence of up to 2714 cd/m2, while the Pe-LED device with TPBi as ETL has higher peak luminous efficiency of 6.4 cd/A and peak luminous power efficiency of 5.7 lm/W. To our knowledge this is the first report on high brightness light emitting device based on CH(NH2)2 PbBr3 widely known as FAPbBr3 nanocrystals in literature. © The Author(s) 2016

Determination of Superconducting Gap of SmFeAsFxO1-x Superconductors by Andreev Reflection Spectroscopy

The superconducting gap in FeAs-based superconductor SmFeAs(O1-xFx) (x = 0.15 and 0.30) and the temperature dependence of the sample with x = 0.15 have been measured by Andreev reflection spectroscopy. The intrinsic superconducting gap is independent of contacts while many other "gap-like" features vary appreciably for different contacts. The determined gap value of 2D = 13.34 +/-0.47 meV for SmFeAs(O0.85F0.15) gives 2D/kBTC = 3.68, close to the BCS prediction of 3.53. The superconducting gap decreases with temperature and vanishes at TC, in a manner similar to the BCS behavior but dramatically different from that of the nodal pseudogap behavior in cuprate superconductors.Comment: 13 pages, 9 figures, Special Issue of Physica C on Superconducting Pnictide

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

The ATLAS trigger system for LHC Run 3 and trigger performance in 2022

The ATLAS trigger system is a crucial component of the ATLAS experiment at the LHC. It is responsible for selecting events in line with the ATLAS physics programme. This paper presents an overview of the changes to the trigger and data acquisition system during the second long shutdown of the LHC, and shows the performance of the trigger system and its components in the proton-proton collisions during the 2022 commissioning period as well as its expected performance in proton-proton and heavy-ion collisions for the remainder of the third LHC data-taking period (2022–2025)